Sponsored Content

Sponsored by Takeda

In a newly validated utility, the DecisionDx-SCC test can help identify patients with cutaneous squamous cell carcinoma (cSCC) likely to benefit from adjuvant radiation therapy (ART).

This content is sponsored by Amgen and was developed in conjunction with Linda Stein Gold, MD, April Armstrong, MD, both of whom were compensated by Amgen for their participation.

When it comes to improving health outcomes, representation matters! Learn how Johnson & Johnson is collaborating with leaders in the field of dermatology and striving to support diverse talent in dermatology practice and research to advance innovative solutions for patients.

Given the complexity of the underlying inflammation in patients with AD, an increased understanding of the OX40L pathway can improve our understanding of AD pathogenesis.

Dr. Jonathan Rodrigues highlights challenges in management of patients with chronic spontaneous urticaria and why shared decision-making is critical.

Dr. Jonathan Rodrigues shares insights regarding the assessment of chronic spontaneous urticaria and the impact of delays in diagnosis.

The main ingredients in Hydrinity Accelerated Skin Science's new line of products are hyaluronic acid and peptides.